Neutra Life Sciences Expands Clinical Research Footprint with Strategic Joint Ventures
TL;DR
Neutra Corp's strategic joint ventures in podiatry, radiation oncology, and dermatology position it ahead in the clinical research industry, offering a competitive edge through diversified medical specialties.
Neutra Life Sciences expands its clinical research capabilities by onboarding joint venture sites in podiatry, radiation oncology, and dermatology, enhancing its multi-specialty platform for broader patient services.
By expanding into diverse medical specialties, Neutra Life Sciences aims to improve health outcomes and accelerate the development of innovative treatments, making healthcare more accessible and effective.
Neutra Corp shifts focus from hemp-based cannabis to life sciences, launching joint ventures in podiatry, radiation oncology, and dermatology to innovate clinical research and patient care.
Found this article helpful?
Share it with your network and spread the knowledge!
Neutra Life Sciences, a key player in the clinical research industry and a subsidiary of Neutra Corp (OTC: NTRR), has recently announced the formation of joint venture partnerships with Epic Foot & Ankle Centers, Aspire Hospital Cancer Centers, and Radiant Dermatology & Aesthetics Clinic. These collaborations signify a major expansion in the company's multi-specialty platform, enabling it to address the increasing need for diverse clinical research solutions across various medical fields.
The partnerships allow Neutra Life Sciences to extend its services to a broader patient demographic and assist Contract Research Organizations (CROs) and Sponsors in a wider range of therapeutic areas. Sydney Jim, President and CEO of Neutra Corp, highlighted the strategic importance of these ventures, noting their role in enhancing service offerings and driving innovation in patient care and research.
In a strategic pivot, Neutra Corp has also announced the winding down of VIVIS Corporation, its subsidiary dedicated to hemp-based cannabis, to reallocate resources towards the life sciences sector. This move reflects the company's focus on areas with stable regulatory environments and significant long-term growth prospects, further emphasizing its commitment to advancing clinical research and improving health outcomes.
For those interested in learning more about Neutra Corp's endeavors in the life sciences sector, additional information is available at https://www.neutrainc.com. This expansion and strategic realignment underscore Neutra Life Sciences' dedication to fostering innovative collaborations and pioneering research in the clinical field.
Curated from NewMediaWire
